BridgeMD
New treatment option for Fibrosis Breast
Official title Shockwave in Postoperative Breast Reconstruction Fibrosis
ClinicalTrials.gov ID: NCT06919042
What this study is testing
- What it's testing
- This study evaluates the potential for extracorporeal shockwave therapy to reduce post-operative soft tissue fibrosis.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- people greater than 18 years of age.
- people who have undergone plastic surgery procedures and present in the post-operative period with soft tissue firmness suggestive of...
You likely can't join if
- people with cardiac pacemakers
- Other medical or psychiatric condition that may increase the risk associated with study participation, may complicate subject compliance, or may...
- Proximity of fibrotic tissue directly adjacent to bone
- Face/neck areas are excluded
- Patients who, in the opinion of the investigator, would not be compliant with the schedule of study visits
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.